Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+14.56%)
As of: Nov 16, 2026 · 11:36 AM EST

Elite Pharmaceuticals (ELTP) Share-based Compensation (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted Share-based Compensation of $20,307 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 59.3% from $49,918 a year earlier and down 28.7% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Share-based Compensation (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Share-based Compensation at Elite Pharmaceuticals was $123,043, down 45.4% year-over-year; for FY2026 (ended Mar 31, 2026), it was $176,507, down 22.4% from FY2025.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 68.0% (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' Share-based Compensation was $227,565 in FY2025 (+42.3%), $159,921 in FY2024 (+306.7%), $39,325 in FY2023 (+174.0%) and $14,353 in FY2022 (+8.9%).
  • The fiscal Q2 2027 figure stands as the lowest quarterly Share-based Compensation since fiscal Q1 2024.
  • On a year-over-year basis, Share-based Compensation has declined in each of the last five quarters, with an average decline of 18.5% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was fiscal Q2 2024, with growth of 616.1%; the weakest was fiscal Q2 2027, with a decline of 59.3%.
  • According to Business Quant data, Share-based Compensation for the three prior fiscal quarters was $28,476 (Q1 2027), $29,164 (Q4 2026) and $45,096 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,292.38 Bn 1,265.99 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 685.50 Bn 605.36 Bn 17.30 Bn 357.00 Mn
3 AbbVie 526.37 Bn 494.37 Bn 13.12 Bn 160.00 Mn
4 Merck 362.03 Bn 324.97 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 313.25 Bn 286.48 Bn - -
6 Astrazeneca 286.56 Bn 260.08 Bn 13.26 Bn -
7 Amgen 253.40 Bn 205.05 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 210.31 Bn 185.42 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.24 Bn 112.60 Bn 12.56 Bn 362.00 Mn
10 Elite Pharmaceuticals 395.52 Mn 268.93 Mn 15.99 Mn 20,307.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20,307.00
Jun 30, 2026 28,476.00
Mar 31, 2026 29,164.00
Dec 31, 2025 45,096.00
Sep 30, 2025 49,918.00
Jun 30, 2025 52,329.00
Mar 31, 2025 52,329.00
Dec 31, 2024 70,578.00
Sep 30, 2024 52,329.00
Jun 30, 2024 52,329.00
Mar 31, 2024 52,329.00
Dec 31, 2023 49,815.00
Sep 30, 2023 42,777.00
Jun 30, 2023 15,000.00
Mar 31, 2023 15,000.00
Dec 31, 2022 13,029.00
Sep 30, 2022 5,974.00
Jun 30, 2022 5,322.00
Mar 31, 2022 3,736.00
Dec 31, 2021 3,630.00
API Access

Elite Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ELTP&period=max&api_key=YOUR_API_KEY